Stocks · Healthcare · Biotechnology
Ginkgo Bioworks Holdings, Inc. DNA
$12.35 -1.20% Close, Oct 2, 2026 · NYSE · Market cap $806.8M
High risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -259.9% from -135.7% a year earlier.
- Revenue over the last four quarters was $111.9M, down 51.5% from a year earlier, slowing from -40.5% a quarter earlier.
- The diluted share count rose 13.2% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 11%
- Revenue growth, 3-year CAGRBottom 6%
- Revenue growth accelerationBottom 17%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 40%
- Gross marginTop 30%
- Operating marginBottom 22%
- Accruals (lower is better)Top 28%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 18%
- Free-cash-flow yieldBottom 22%
- EBITDA / enterprise valueBottom 29%
- Sales / enterprise valueBottom 30%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 6%
- 6-month returnTop 12%
- 1-year return vs S&P 500Bottom 32%
- Distance from 52-week highTop 46%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 44%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 6%
- Upside to consensus price targetBottom 1%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 8%
- Maximum drawdown, 3 yearsBottom 10%
- Beta vs S&P 500 (lower is better)Bottom 2%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -40.5% | -51.5% | ↓ |
| Gross margin | 79.9% | 80.1% | ↑ |
| Operating margin | -135.7% | -259.9% | ↓ |
| FCF margin | -118.8% | -170.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -51.5% | -40.5% | ↓ | Bottom 11% |
| Gross margin | 80.1% | 79.9% | ↑ | Top 30% |
| Operating margin | -259.9% | -135.7% | ↓ | Bottom 22% |
| Net margin | -260.0% | -136.6% | ↓ | — |
| Free-cash-flow margin | -170.0% | -118.8% | ↓ | — |
| Return on invested capital | -31.6% | — | Bottom 40% | |
| Revenue growth, 3-year CAGR | -29.1% | — | Bottom 6% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -12.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 55.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +7.8 pp
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -2.25%
- Shareholder yield
- -2.25%
- Share count change, 1 year
- +13.2%
- Share count change, 3-year CAGR
- +8.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +1.4%
- Average 2-day reaction, last 8
- -1.6%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $5.00
- Target vs current price
- -59.5%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 36%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +16.2% | +0.0% | -19.9% | -26.0% | — |
| May 7, 2026 | -14.8% | +2.4% | -14.8% | -10.2% | -11.3% |
| Feb 26, 2026 | +21.1% | +3.5% | -28.7% | -21.5% | -13.9% |
| Nov 6, 2025 | -16.9% | -2.5% | -27.9% | -20.5% | -24.2% |
| Aug 7, 2025 | +23.6% | -3.6% | -5.0% | -16.3% | -14.0% |
| May 6, 2025 | -36.6% | -6.8% | +20.1% | +8.1% | +89.9% |
| Feb 25, 2025 | -25.5% | -1.6% | -23.4% | -26.4% | -23.6% |
| Nov 12, 2024 | +60.3% | -4.2% | -27.7% | +25.9% | +54.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.75 | -$0.90 | +16.2% | $20.2M |
| May 7, 2026 | -$1.39 | -$1.21 | -14.8% | $19.5M |
| Feb 26, 2026 | -$1.42 | -$1.80 | +21.1% | $33.0M |
| Nov 6, 2025 | -$1.45 | -$1.24 | -16.9% | $38.8M |
| Aug 7, 2025 | -$1.10 | -$1.44 | +23.6% | $49.6M |
| May 6, 2025 | -$1.68 | -$1.23 | -36.6% | $48.3M |
| Feb 25, 2025 | -$1.82 | -$1.45 | -25.5% | $43.8M |
| Nov 12, 2024 | -$1.08 | -$2.72 | +60.3% | $89.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 10.07× | — | — | Bottom 30% |
| Free-cash-flow yield | -23.57% | — | — | Bottom 22% |
| Earnings yield | -40.65% | — | — | Bottom 18% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 12
- Days above the 200-day average
- 9
- 50-day average slope (20 days)
- -1.1%
- 200-day average slope (20 days)
- +0.1%
- Distance from 50-day average
- +52.9%
- Distance from 200-day average
- +48.4%
- RSI (14)
- 74.7
- Relative volume
- 1.02×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 100.0%
- Volatility vs own 5-year history
- 61th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 3.09
- Correlation with S&P 500
- 0.43
- Current drawdown from 1-year high
- -23.5%
- Maximum drawdown, 3 years
- -92.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 9, 2021 | Sep 9, 2024 | -99.1% | 710 days | Not yet recovered |
| Sep 27, 2021 | Oct 11, 2021 | -28.7% | 10 days | 6 days (Oct 19, 2021) |
| Apr 23, 2021 | Sep 13, 2021 | -11.8% | 98 days | 3 days (Sep 16, 2021) |
| Oct 19, 2021 | Oct 22, 2021 | -11.3% | 3 days | 11 days (Nov 8, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $806.8M
- EPS, diluted (TTM)
- -$5.02
- Revenue (TTM)
- $111.9M
- 52-week range
- $5.37 – $17.58
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $313.8M | $477.7M | $251.5M | $227.0M | $170.2M |
| Gross profit | $184.1M | $273.5M | $197.4M | $188.5M | $138.6M |
| Operating income | -$1.83B | -$2.21B | -$864.4M | -$559.8M | -$315.3M |
| Net income | -$1.83B | -$2.10B | -$892.9M | -$547.0M | -$312.8M |
| EPS (diluted) | -$55.53 | -$50.20 | -$18.40 | -$10.54 | -$5.64 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $89.0M | $43.8M | $48.3M | $49.6M | $38.8M | $33.4M | $19.5M | $20.2M |
| Net income | -$56.4M | -$107.5M | -$91.0M | -$60.3M | -$80.8M | -$80.8M | -$82.6M | -$46.7M |
| EPS (diluted) | -$1.08 | -$2.07 | -$1.68 | -$1.10 | -$1.45 | -$1.43 | -$1.39 | -$0.75 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$253.8M | -$252.2M | -$295.5M | -$319.6M | -$171.1M |
| Capital expenditure | -$56.5M | -$52.3M | -$40.8M | -$62.5M | -$7.7M |
| Free cash flow | -$310.3M | -$304.5M | -$336.3M | -$382.1M | -$178.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$25.0M | $99.3M | -$23,000 | $80,000 | $19.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $302.2M
- Total assets
- $990.0M
- Total liabilities
- $569.8M
- Total debt
- $404.1M
- Net debt
- $319.6M
- Shareholders’ equity
- $420.3M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 7,166,128
- Days to cover
- 7.20
- Change vs previous report
- +4.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Aug 20, 2024
- 1-for-40